Skip to content
Search

Latest Stories

Cold and cough management: Why environmental and lifestyle data matters?

Cold and cough management: Why environmental and lifestyle data matters?

Experts explain how pharmacists can leverage environmental and lifestyle data to provide more comprehensive advice to patients for effective management of cold and cough symptoms

As local GP services face increasing pressure, the role of pharmacists in managing minor ailments such as cold and cough has become more crucial than ever.


Considering environmental and lifestyle factors, such as pollution levels, pollen counts, smoking, and diet, is essential for the effective management of respiratory conditions.

In this article, experts explain how pharmacists can leverage these factors to provide more comprehensive advice to patients for managing cold and cough symptoms.

Dr Roger Henderson, GP and spokesperson for Olbas, says: “Environmental factors play a critical role in the exacerbation and management of respiratory conditions. For example, high pollution levels can aggravate cold and cough symptoms, particularly in areas where air quality can drastically fluctuate.

“By assessing real-time pollution data, pharmacists can advise patients to take precautions on days when pollution levels are high.”

Air pollution is well known to increase the risk of certain respiratory diseases.

Dr. Henderson explains that this is especially true with particulate pollen, which can penetrate the respiratory system when inhaled.

“Air pollution also makes individuals more vulnerable to infectious respiratory diseases, including colds, due to the effect of pollution on the body’s immune response,” he adds.

Moreover, the severity of hay fever is directly affected by the levels of atmospheric pollen.

Dr. Henderson believes that pharmacists, being deeply rooted in their communities, are ideally positioned to raise public awareness about the health threats posed by air pollution and pollen counts and support them in mitigating the risks.

He notes that simple advice such as pollen avoidance, the use of nasal sprays and masks, and hygiene tips can improve both outcome and patient satisfaction when given by pharmacists.

He expounds: “Patients with hay fever can be optimally advised about symptom prevention by community pharmacists if pollen level alerts are known in advance or if they suddenly spike.

“Patients with respiratory conditions such as COPD can also be given advice as to how to step up their preventive treatments if it’s known that atmospheric pollution is about to increase, along with a deterioration in air quality.”

Dr. Henderson underscores the importance of a holistic approach to patient care: “Taking a holistic approach with a patient provides the best chance of that patient obtaining the best advice to improve their health.”

He encourages pharmacists to consider a patient’s smoking history and nutritional status when managing cold and cough symptoms.

“Anyone presenting with a cough or cold should be asked about their smoking history and nutrition as they may be more likely to be at risk of minor ailments if their lifestyle or economic status means they are malnourished,” he says.

Rachel Anthony, Olbas Brand Manager, points out that with the mounting pressure on local GP services, pharmacists are relied on more than ever and are positioned to offer more personalised advice to patients in managing cough and cold symptoms.

She stresses that integrating environmental data such as pollution levels and pollen counts, along with lifestyle factors like smoking and diet, can significantly enhance the quality of care provided.

Rachel also highlights the importance of equipping pharmacies with a robust supply of trusted OTC brands, especially during peak cold and flu seasons.

“By monitoring environmental data and considering patients' lifestyle factors, pharmacists can be better equipped for an uplift in demand for cold and flu remedies,” she says.

To further enhance patient care, Rachel advocates for offering a diverse range of products and formats.

“Ensuring to offer a mix of products and formats will also ensure pharmacists meet the demand from cold and flu symptoms.

“Offering ‘on-the-go’ solutions also provides a convenient remedy for consumers, allowing them to alleviate their symptoms with ease.”

The Olbas Inhaler, for example, provides an instant, portable remedy for nasal congestion, perfect for quick relief on the move,” she adds.

Olbas products are distributed by Lanes Health, a family-owned business based in Gloucester.

Elizabeth Hughes-Gapper, Senior Brand Manager at Jakemans, also stresses that integrating environmental data such as pollution levels and pollen counts, can significantly enhance the advice pharmacists provide for managing cold and cough symptoms.

“Poor air quality and high pollen counts can exacerbate respiratory symptoms like coughing which leads to sore throats. By monitoring these factors, pharmacists can offer more personalised advice,” she notes.

Elizabeth also emphasises the importance of keeping updated on the latest innovative platforms, like Google Maps new feature which tracks air quality and pollen information. “This can help pharmacists better understand the environmental conditions affecting their patients and tailor their advice accordingly,” she says.

She encourages pharmacists to suggest preventive measures that align with current consumer trends and address common cold and cough symptoms.

Elizabeth points out that, with 80 per cent of people having experienced a cough and 72 per cent a sore throat in the past year, it’s essential to stock a variety of over-the-counter (OTC) remedies, particularly throat lozenges.

More For You

Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less